Paulo Fontoura resigns from Lakefront Biotherapeutics board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. TFII
9. LYB
10. RXRX

Go back to Paulo Fontoura resigns from Lakefront Biotherapeutics board

Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi

July 13, 2026 4:01 PM EDT

Mechelen, Belgium; July 13, 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that following his appointment as Executive Vice President, Global Head of Research & Development Pharma at Sanofi SA, Dr. Paulo Fontoura has tendered his resignation from the Board of Directors.

I want to congratulate Paulo on this important assignment and sincerely thank him for his insight and guidance during his tenure on our Board, said Gino Santini, Chair of the Board of Directors. We wish him the best of luck in his new position and we expect to appoint a successor at the... More